BI 456906 · GLP-1/Glucagon Dual Agonist
Dual GLP-1 and glucagon receptor agonist from Boehringer Ingelheim pipeline. Studied in metabolic and hepatic research models with strong glucagon component.
Survodutide (BI 456906) is a subcutaneous dual agonist co-activating GLP-1 and glucagon receptors. Its relatively high glucagon receptor activation is of research interest for models studying energy expenditure, hepatic lipid metabolism, and NASH/MAFLD pathways.
Store lyophilized at -20°C. Reconstitute in bacteriostatic water. Stable 4 weeks at 2–8°C after reconstitution.